Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Nuclear Medicine and Biology|February 7, 2006
Polymer-peptide conjugates for angiogenesis targeted tumor radiotherapyAmitava Mitra, Anjan Nan, John C Papadimitriou, et al.Nano Letters|July 16, 2008
Cellular uptake and cytotoxicity of silica nanotubesAnjan Nan, Xia Bai, Sang Jun Son, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|January 18, 2005
Targeting tumor angiogenic vasculature using polymer-RGD conjugatesAmitava Mitra, Justin Mulholland, Anjan Nan, et al.Molecular Cancer Therapeutics|November 21, 2007
A prostate-specific antigen activated N-(2-hydroxypropyl) methacrylamide copolymer prodrug as dual-targeted therapy for prostate cancerSachin S Chandran, Anjan Nan, D Marc Rosen, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|August 8, 2006
Polymeric conjugates of mono- and bi-cyclic alphaVbeta3 binding peptides for tumor targetingAmitava Mitra, Tomika Coleman, Mark Borgman, et al.Pharmaceutical Research|April 10, 2013
Riboflavin-targeted polymer conjugates for breast tumor deliveryLisa M Bareford, Brittany R Avaritt, Hamidreza Ghandehari, et al.Pharmaceutical Research|August 5, 2004
Technetium-99m-Labeled N-(2-hydroxypropyl) methacrylamide copolymers: synthesis, characterization, and in vivo biodistributionAmitava Mitra, Anjan Nan, Hamidreza Ghandehari, et al.Journal of Drug Targeting|July 23, 2005
Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neckAnjan Nan, Hamidreza Ghandehari, Carla Hebert, et al.Bioconjugate Chemistry|October 23, 2010
Multiphoton-absorption-induced-luminescence (MAIL) imaging of tumor-targeted gold nanoparticlesMatthew B Dowling, Linjie Li, Juhee Park, et al.Organic & Biomolecular Chemistry|March 8, 2012
Relaxation of the rigid backbone of an oligoamide-foldamer-based α-helix mimetic: identification of potent Bcl-xL inhibitorsJeremy L Yap, Xiaobo Cao, Kenno Vanommeslaeghe, et al.Pageof 2